Translations:Dipeptidyl peptidase-4 inhibitor/16/en
Jump to navigation
Jump to search
A 2014 meta-analysis found no evidence for increased pancreatic cancer risk in people treated with DPP-4 inhibitors, but owing to the modest amount of data available, was not able to completely exclude possible risk.